|
Volumn 37, Issue 4, 2007, Pages 969-1049
|
Curbing industry sponsor's incentive to design post-approval trials that are suboptimal for informing prescribers but more likely than optimal designs to yield favorable results.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG;
ALTERNATIVE MEDICINE;
ARTICLE;
CLINICAL PRACTICE;
CLINICAL PROTOCOL;
COST BENEFIT ANALYSIS;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG INDUSTRY;
ECONOMICS;
EPIDEMIOLOGY;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT REGULATION;
HEALTH INSURANCE;
HOSPITALIZATION;
HUMAN;
INFORMATION SERVICE;
INSURANCE;
METHODOLOGY;
MOTIVATION;
ORGANIZATION AND MANAGEMENT;
PATIENT SELECTION;
PHASE 4 CLINICAL TRIAL;
POLICY;
POSTMARKETING SURVEILLANCE;
PUBLICATION;
PUBLISHING;
QUALITY CONTROL;
RACE;
TIME;
TREATMENT OUTCOME;
UNITED STATES;
CLINICAL PROTOCOLS;
CLINICAL TRIALS, PHASE IV AS TOPIC;
COMPLEMENTARY THERAPIES;
CONTINENTAL POPULATION GROUPS;
COST-BENEFIT ANALYSIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG APPROVAL;
DRUG INDUSTRY;
EPIDEMIOLOGIC FACTORS;
FINANCIAL SUPPORT;
FORMULARIES;
GOVERNMENT REGULATION;
HUMANS;
INFORMATION SERVICES;
INSURANCE COVERAGE;
INSURANCE, PHARMACEUTICAL SERVICES;
MOTIVATION;
ORGANIZATIONAL POLICY;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
PATIENT SELECTION;
PHARMACEUTICAL PREPARATIONS;
PHYSICIAN'S PRACTICE PATTERNS;
PRIVATE SECTOR;
PRODUCT SURVEILLANCE, POSTMARKETING;
PUBLIC SECTOR;
PUBLICATION BIAS;
QUALITY CONTROL;
RESEARCH DESIGN;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 41949120944
PISSN: 05865964
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|